School of Medicine


Showing 3,831-3,840 of 4,709 Results

  • Sam Shen

    Sam Shen

    Clinical Professor, Emergency Medicine

    Current Research and Scholarly InterestsEmergency Department process improvement
    Digital Health
    ED operations
    ED innovations

  • Yelizaveta Sher, MD, FACLP

    Yelizaveta Sher, MD, FACLP

    Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry

    BioDr. Sher received her BA from UC Berkeley and MD from Washington University in St. Louis. She completed Residency in Psychiatry and Fellowship in Psychosomatic Medicine at Stanford University Medical Center. She has been a part of Psychosomatic Medicine Faculty, now a Division of Medical Psychiatry, at Stanford since 2013. Her areas of clinical and research interests include psychiatric comorbidities in patients with pulmonary disorders. In particular, she specializes in mental health of patients with cystic fibrosis as well as lung and heart transplant patients. She consults on patients hospitalized on medical and surgical units as well as sees patients in outpatient clinics. She serves as the Director of Psychiatric and Psychological Services for the Adult Cystic Fibrosis Clinic and Chief of Psychosomatic Medicine Clinic. She has published many articles and book chapters and edited several books related to her fields of interest and expertise.

  • Gavin Sherlock

    Gavin Sherlock

    Professor of Genetics

    Current Research and Scholarly InterestsEvolution and the adaptive landscape using yeast as a model; Defining yeast transcriptomes; chromosomal evolution in hybrid yeast species

  • Seth Lawrence Sherman, MD

    Seth Lawrence Sherman, MD

    Associate Professor of Orthopaedic Surgery

    Current Research and Scholarly InterestsMy research focuses on ways to augment tissue healing, improve human performance, and prevent musculoskeletal injuries. Approaching these challenges through parallel basic science and clinical pathways, our team works from the “bedside to the bench and back to the bedside”, identifying areas of clinical need to deliver evidence-based solutions for patients.

    We collaborates with orthopaedic surgeons, non-surgical physicians, and researchers within bioengineering, human performance, and musculoskeletal imaging across the Stanford campus. The team is developing novel methods to accurately record human movement (including wearable technology, phone-based systems), rapid MRI imaging protocols, and exploring the use of biomarkers to track injury and recovery. This research builds on my earlier work, which utilized portable, inexpensive software for Microsoft Kinect to detect knee injury risk in youth athletes performing a drop vertical jump test. The team’s multifaceted goal is: 1) develop innovative methods to screen for injury risk (i.e. youth athlete non-contact ACL), 2) create targeted intervention programs to reduce risk, 3) enhance athletic performance; and 4) improve accuracy of return to play testing following injury/surgery (i.e. clinical evaluation, biomarkers, functional tests, imaging analysis for healing).

    In the laboratory,our team investigates cellular and molecular deficiencies in tissue types including tendon, ligament, articular cartilage, and meniscus. By understanding aberrant pathways leading to tissue injury, they can identify innovative therapeutic targets for intervention. In collaboration with the Genetic Engineering and Synthetic Biology laboratories, Dr. Sherman’s research has explored the role of orthobiologic agents such as platelet rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) for tissue healing in patella tendinopathy (the breakdown of collagen in a tendon). Our lab is also investigating the use of CBD for musculoskeletal applications as an alternative to commonly used local anesthetics and cortisone derivatives. In my earlier work, we researched the cellular toxicity of such applications.

    In addition to basic science research, I have helped to build a Sports Medicine clinical research team that includes several full-time clinical research coordinators, residents, fellows, and students. The team collects prospective outcomes on their patients using a novel data collection platform called Patient IQ. The group is part of the JUPITER study which is the largest, multicenter study ever assembled in patellofemoral instability. They are additionally planning to enroll in FDA-approved clinical studies investigating pioneering strategies for knee cartilage restoration, joint preservation, and orthobiologic injections for osteoarthritis. Recent clinical publications explore outcomes in meniscus preservation and transplantation, medial patellofemoral ligament reconstruction, osteochondral allograft and matrix-induced autologous chondrocyte implantation (MACI), and surgical augmentation using PRP/BMAC. The clinical research team actively reports results of non-surgical and surgical interventions to continue to introduce new knowledge to the field, with the goal of improved patient outcome.

  • Bansari Sureshchandra Sheth

    Bansari Sureshchandra Sheth

    Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Sheth is originally from southern California, but has progressively moved up the coast over the last few years, now making the Bay Area her wonderful new home. Board certified in Family Medicine, she had comprehensive training during residency. She has a variety of special interests, including pediatric illnesses, women’s health, diabetes care including lifestyle management, as well as Hepatitis C treatment. She believes in empowering her patients, working together with them as a team. In her free time, Dr. Sheth enjoys yoga, going to plays or musicals, comedy shows, and hiking.

  • Kunj Sheth

    Kunj Sheth

    Assistant Professor of Urology

    BioDr. Kunj Sheth is a pediatric urologist who focuses on minimally-invasive approaches to children’s surgery and treatment of complex patients. She is currently in the Biodesign Faculty Fellows Program. Her research focuses on the design and development of health technology specifically for children. She is also working to improve surgical education for residents through 3-dimensional modeling for minimally-invasive surgery. She is a part of the UCSF-Stanford Pediatric Device Consortium. Kunj graduated from Northwestern University with an undergraduate degree in biomedical engineering. She attended Northwestern University Feinberg School of Medicine and completed a Urology residency training program at the University of Texas Southwestern Medical Center. She then completed a fellowship in Pediatric Urology at Baylor College of Medicine - Texas Children's Hospital.

  • Vipul Sheth

    Vipul Sheth

    Assistant Professor of Radiology (Body MRI)

    Current Research and Scholarly InterestsMy interests are in the development and translation of imaging technologies geared toward disease detection and characterization to better guide prognosis, treatment, and improve outcomes. I’m interested in supporting the development of MRI guided focal therapy methods which can personalize treatment and reduce the risk of morbidity from more invasive therapies.

    Clinical Interests

    - MRI for diagnosis of pelvic floor disorders
    - MRI and PET/MRI to pelvic malignancies and lymph node staging.
    - Whole Body MRI
    - MRI guided procedures including biopsies, cryoablation, and high intensity focused ultrasound.

    Translational Research Interests

    - Development and translation of magnetic resonance imaging technologies to improve both diagnostics and therapeutics
    - Molecular imaging and characterization of the tumor microenvironment
    - Ultrashort echo time MRI applications in the body
    - Developing synergistic MRI methods to complement PET in potential applications for PET/MRI

  • Run Zhang Shi

    Run Zhang Shi

    Clinical Associate Professor, Pathology

    Current Research and Scholarly InterestsClinical chemistry and therapeutic drug monitoring;
    adult and pediatric clinical endocrine testing;
    screening, detection and follow up of multiple myeloma;
    tumor markers;
    clinical utility of tandem mass spectrometry and high resolution mass spectrometry.